Future Directions in the Second-Line Treatment of Non-Small Cell Lung Cancer Fulltext Access 7 Pages 2006
The Emergence of a Unique Population in Non-Small Cell Lung Cancer: Systemic or Loco-Regional Relapse Following Postoperative Adjuvant Platinum-Based Chemotherapy Fulltext Access 7 Pages 2006
Clinical Experience: Practical Management of Five Patients With Cutaneous T-Cell Lymphoma (CTCL)-Related Symptoms Fulltext Access 7 Pages 2006
Cardiotoxic Consequences of Anthracycline-Containing Therapy in Patients With Breast Cancer Fulltext Access 7 Pages 2006
New and Emerging Intraperitoneal (IP) Drugs for Ovarian Cancer Treatment Fulltext Access 7 Pages 2006
Genomics of Chronic Lymphocytic Leukemia MicroRNAs as New Players With Clinical Significance Fulltext Access 7 Pages 2006
Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors Fulltext Access 7 Pages 2006
The Role of Gemcitabine in First-Line Treatment of Advanced Ovarian Carcinoma Fulltext Access 7 Pages 2006
Selecting Endocrine Therapy for Breast Cancer: What Role Does HER-2/neu Status Play? Fulltext Access 7 Pages 2006
Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Current Status and Future Applications Fulltext Access 7 Pages 2006
Survivin-Dependent and -Independent Pathways and the Induction of Cancer Cell Death by Tetra-O-methyl Nordihydroguaiaretic Acid Fulltext Access 7 Pages 2006
Bevacizumab in Older Patients and Patients With Poorer Performance Status Fulltext Access 7 Pages 2006
Bevacizumab in Combination With Chemotherapy: First-Line Treatment of Patients With Metastatic Colorectal Cancer Fulltext Access 7 Pages 2006
Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer Fulltext Access 7 Pages 2006
Changing the course of oncogenesis: The development of tyrosine kinase inhibitors Fulltext Access 7 Pages 2006
Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy Fulltext Access 7 Pages 2006
The New Generation of Platelet Additive Solution for Storage at 22°C: Development and Current Experience Fulltext Access 7 Pages 2006
Safety of RBC apheresis and whole blood donation in allogeneic and autologous blood donors Fulltext Access 7 Pages 2006
Local experience with thrombotic thrombocytopenic purpura from the western part of Turkey Fulltext Access 7 Pages 2006
Salvaging of liquid-preserved O-positive and O-negative red blood cells by rejuvenation and freezing Fulltext Access 7 Pages 2006
Cytapheresis in the treatment of cell-affected blood disorders and abnormalities Fulltext Access 7 Pages 2006
The Angiogenic Switch Molecule, Secreted FGF-Binding Protein, an Indicator of Early Stages of Pancreatic and Colorectal Adenocarcinoma Fulltext Access 7 Pages 2006
The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells Fulltext Access 7 Pages 2006
Recent Advances in the Treatment of Childhood Immune Thrombocytopenic Purpura Fulltext Access 7 Pages 2006
General Approach to, and Perspectives on Clinical Research in, Older Patients With Newly Diagnosed Acute Myeloid Leukemia Fulltext Access 7 Pages 2006
New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management Fulltext Access 7 Pages 2006
Granulocyte function is stimulated by a novel hexapeptide, WKYMVm, in chemotherapy-treated cancer patients Fulltext Access 7 Pages 2006
PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma Fulltext Access 7 Pages 2006
Lipid raft disruption prevents apoptosis induced by 2-chloro-2′-deoxyadenosine (Cladribine) in leukemia cell lines Fulltext Access 7 Pages 2006
Aberrant DNA demethylation in promoter region and aberrant expression of mRNA of PAX4 gene in hematologic malignancies Fulltext Access 7 Pages 2006
Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-α-expressing cells Fulltext Access 7 Pages 2006
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice Fulltext Access 7 Pages 2006
The role of leukemia-derived B7-H1 (PD-L1) in tumor–T-cell interactions in humans Fulltext Access 7 Pages 2006
Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation Fulltext Access 7 Pages 2006
Increased α2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells Fulltext Access 7 Pages 2006
Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood Fulltext Access 7 Pages 2006
Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome Fulltext Access 7 Pages 2006
Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins Fulltext Access 7 Pages 2006
Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation Fulltext Access 7 Pages 2006
In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients Fulltext Access 7 Pages 2006
A Stro-1+ human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system Fulltext Access 7 Pages 2006
Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma Fulltext Access 7 Pages 2006
Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: Fast engraftment and low toxicity Fulltext Access 7 Pages 2006
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations Fulltext Access 7 Pages 2006
Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia Fulltext Access 7 Pages 2006
Aromatase inhibitors in the early adjuvant setting – the latest evidence Fulltext Access 7 Pages 2006
Reduced expression of TGF β1RII in agnogenic myeloid metaplasia is not due to mutation or methylation Fulltext Access 7 Pages 2006
Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biology Fulltext Access 7 Pages 2006
Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia Fulltext Access 7 Pages 2006
Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines Fulltext Access 7 Pages 2006
Different γ/δ T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation Fulltext Access 7 Pages 2006
Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL) Fulltext Access 7 Pages 2006
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse Fulltext Access 7 Pages 2006
Prevalence of MDS subtypes in Shanghai, China: A comparison of the World Health Organization and French American British classifications Fulltext Access 7 Pages 2006
Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia Fulltext Access 7 Pages 2006
Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse Fulltext Access 7 Pages 2006
Continuous monitoring of WBC (biochemistry) in an adult leukemia patient using advanced FTIR-spectroscopy Fulltext Access 7 Pages 2006
Are myelodysplastic syndromes “cancer”?: Unexpected adverse consequences of linguistic ambiguity Fulltext Access 7 Pages 2006
Current and future directions for adjuvant chemotherapy in early-stage breast cancer Fulltext Access 7 Pages 2006
Berbamine: A novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity Fulltext Access 7 Pages 2006
Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells Fulltext Access 7 Pages 2006
Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes Fulltext Access 7 Pages 2006
Aven overexpression: Association with poor prognosis in childhood acute lymphoblastic leukemia Fulltext Access 7 Pages 2006
HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24 Fulltext Access 7 Pages 2006
Classification and scoring systems in myelodysplastic syndromes: A retrospective analysis of 311 patients Fulltext Access 7 Pages 2006
Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome Fulltext Access 7 Pages 2006
Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia Fulltext Access 7 Pages 2006
Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients—implications for RQ-PCR-based assessment of minimal residual disease Fulltext Access 7 Pages 2006
A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement Fulltext Access 7 Pages 2006
Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by arsenic sulphide: Involvement of serine/threonine protein phosphatases Fulltext Access 7 Pages 2006